Stay updated on ADU-S100 Combination in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the ADU-S100 Combination in Head and Neck Cancer Clinical Trial page.

Latest updates to the ADU-S100 Combination in Head and Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for the ADU-S100 and pembrolizumab head and neck cancer trial, including its terminated status, outcome information, eligibility criteria, locations, and study documents.SummaryDifference46%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov 403 error page displays an updated site revision number in its footer.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study details with an access-restricted page and concealing the associated documents and information.SummaryDifference17%

- Check60 days agoChange DetectedThe page's revision metadata was updated from v3.6.6 to v3.7.0, representing a version update to the page's underlying content. This change does not alter the study information or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to ADU-S100 Combination in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADU-S100 Combination in Head and Neck Cancer Clinical Trial page.